Mobilise-D releases a new video explaining its clinical trials

The Mobilise-D project has released a new video about the Mobilise-D Clinical Study!

Being able to remotely monitor patients’ mobility in their natural environment is a major advantage, both in lockdown and in general. To meet the societal need for better mobility assessment, Mobilise-D will follow up the ongoing technical validation study with a large-scale clinical study that will include 2400 patients from four different cohorts across different sites in Europe. The use of wearable digital technology allows clinicians, researchers and industry alike to measure and monitor real world mobility, including the home and the community, and detect mobility loss such as reduced walking speed.

One of the patient groups included in the Mobilise-D studies are people with Parkinson’s disease. In this group, mobility deficits can potentially occur up to five years before being diagnosed, says neurologist Prof. Dr. med. Walter Maetzler from Mobilise-D.

“In the Mobilise-D clinical validation study, participants will be asked to wear a small sensor on their back for up to nine consecutive days, to let us learn, assess and objectively measure mobility during daily, real world life,” says physiotherapist Dr. Stefanie Mikolaizak from Mobilise-D.

The results from the Mobilise-D studies will provide valuable information for clinical practice, and help adults impacted by mobility loss receive personalised healthcare. And the public is aware of these benefits as well:

“If that was available, a small device that could track how I’m doing in my daily life, in terms of mobility, I think that would be really useful, and I think many people that I know would find that really useful.” – Eleanor

[VIDEO] Introducing the Mobilise-D Clinical Trials